Invesco Portfolio holdings
Invesco Ltd., founded in 1978 and headquartered in Atlanta, Georgia, is a global investment management firm managing hundreds of billions in assets across a diverse range of products, including mutual funds, exchange-traded funds (ETFs), and institutional portfolios. Known for its blend of active and passive investment strategies, Invesco serves individual investors, financial advisors, and institutions, with a strong presence in North America, Europe, and Asia, bolstered by acquisitions like OppenheimerFunds in 2019. The firm offers specialized solutions in equities, fixed income, real estate, and alternatives, leveraging its global research capabilities to cater to varying market needs. Invesco’s commitment to innovation and client-focused investing has solidified its reputation as a versatile player in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$381M |
| 2 |
Philip Morris
PM
|
+$339M |
| 3 |
DuPont de Nemours
DD
|
+$270M |
| 4 |
Altria Group
MO
|
+$268M |
| 5 |
Fox Class A
FOXA
|
+$161M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
|
+$513M |
| 2 |
TFCF
Twenty-First Century Fox, Inc. Class B
TFCF
|
+$362M |
| 3 |
Merck
MRK
|
+$350M |
| 4 |
FITB
Fifth Third Bancorp
FITB
|
+$277M |
| 5 |
Pfizer
PFE
|
+$262M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.76% |
| 2 | Financials | 12.8% |
| 3 | Consumer Discretionary | 11.91% |
| 4 | Healthcare | 10.98% |
| 5 | Communication Services | 9.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3351
TIM SA
TIMB
$9.16B
| $341K | ﹤0.01% |
22,598
+9,679
| +75% | +$156K |
|
|
FEN
3352
DELISTED
First Trust Energy Income and Growth Fund
FEN
| $341K | ﹤0.01% |
15,671
-19,624
| -56% | -$408K |
|
3353
Byline Bancorp
BY
$1.78B
| $340K | ﹤0.01% |
+18,418
| New | +$346K |
|
|
NWHM
3354
DELISTED
THE NEW HOME COMPANY INC.
NWHM
| $340K | ﹤0.01% |
71,444
+37,291
| +109% | +$223K |
|
|
EVM
3355
DELISTED
Eaton Vance California Municipal Bond Fund
EVM
| $339K | ﹤0.01% |
32,093
-36,743
| -53% | -$382K |
|
|
EGIO
3356
DELISTED
Edgio, Inc. Common Stock
EGIO
| $339K | ﹤0.01% |
2,623
-741
| -22% | -$86K |
|
3357
Ericsson
ERIC
$32.2B
| $334K | ﹤0.01% |
36,341
-18,541
| -34% | -$168K |
|
3358
MacroGenics
MGNX
$235M
| $334K | ﹤0.01% |
18,603
+1,947
| +12% | +$33.7K |
|
3359
NVE Corp
NVEC
$562M
| $331K | ﹤0.01% |
3,380
-1,906
| -36% | -$184K |
|
3360
Silicom
SILC
$229M
| $330K | ﹤0.01% |
+8,629
| New | +$313K |
|
|
AXDX
3361
DELISTED
Accelerate Diagnostics
AXDX
| $329K | ﹤0.01% |
1,564
+151
| +11% | +$28.3K |
|
3362
CRH
CRH
$63.2B
| $329K | ﹤0.01% |
10,619
-5,419
| -34% | -$162K |
|
|
OMN
3363
DELISTED
OMNOVA Solutions Inc.
OMN
| $327K | ﹤0.01% |
46,571
-107,927
| -70% | -$862K |
|
3364
Gerdau
GGB
$9.74B
| $325K | ﹤0.01% |
105,659
-102,949
| -49% | -$334K |
|
3365
Metropolitan Bank Holding Corp
MCB
$1.15B
| $323K | ﹤0.01% |
+9,276
| New | +$332K |
|
3366
Dr. Reddy's Laboratories
RDY
$9.87B
| $321K | ﹤0.01% |
39,670
-3,450
| -8% | -$26.2K |
|
|
HNP
3367
DELISTED
Huaneng Power Intl, Inc.
HNP
| $321K | ﹤0.01% |
13,868
-10,574
| -43% | -$262K |
|
3368
CALL
Automatic Data Processing
ADP
$106B
| $320K | ﹤0.01% |
2,000
+1,800
| +900% | +$261K |
|
3369
TherapeuticsMD
TXMD
$23.5M
| $320K | ﹤0.01% |
1,315
+107
| +9% | +$28.3K |
|
3370
AnaptysBio
ANAB
$1.58B
| $319K | ﹤0.01% |
+4,367
| New | +$301K |
|
|
ARQL
3371
DELISTED
Arqule Inc
ARQL
| $319K | ﹤0.01% |
66,821
-115,981
| -63% | -$448K |
|
|
PMD
3372
DELISTED
Psychemedics Corporation
PMD
| $318K | ﹤0.01% |
22,650
-2,318
| -9% | -$39.8K |
|
|
PRMW
3373
DELISTED
Primo Water Corporation
PRMW
| $317K | ﹤0.01% |
21,642
-6,532
| -23% | -$98.1K |
|
|
JMEI
3374
DELISTED
Jumei International Holding Limited American depositary shares, each representing ten Class A ordina
JMEI
| $316K | ﹤0.01% |
13,380
-456
| -3% | -$10.7K |
|
|
MYOK
3375
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $313K | ﹤0.01% |
6,024
-33,717
| -85% | -$1.55M |
|
Similar funds
Invesco's Q1 2019 Portfolio in Review
As of Q1 2019, Invesco held 3,988 positions worth $297B, up 14% from $261B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Invesco's Q1 2019 filing shows 172 new, 1,740 increased, 1,658 reduced and 285 closed positions. Its largest new stake was Fox Class A: 4,126,302 shares worth $151M. The largest sale was Twenty-First Century Fox, Inc. Class A, an estimated $513M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Consumer Discretionary.
- Invesco's largest Q1 2019 buy was Fox Class A: 4,126,302 shares worth $151M.
- Invesco added most to Apple in Q1 2019, an estimated $381M increase.
- Invesco's biggest Q1 2019 reduction was Merck, cutting an estimated $350M.
- Invesco fully exited Twenty-First Century Fox, Inc. Class A in Q1 2019, selling an estimated $513M.
- Invesco's ten largest holdings make up 17% of its $297B portfolio in Q1 2019.
- Invesco opened 172 new positions and closed 285 in Q1 2019.
- Invesco's portfolio value rose 14% quarter-over-quarter to $297B.
Based on Invesco's 13F filing for Q1 2019, filed 15 May 2019.